Norepinephrine bitartrate manufacturers

Filters

Filters

Filters , active

Country of origin : China
None products found

norepinephrine bitartrate

Solution for injection 8 mg/4 ml - 4 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #36625

A pharmaceutical manufacturer engaged in the research, development, manufacture and commercialization of a variety of pharmaceutical products, including finished dosage forms such as capsules, tablets and injections as well as active pharmaceutical ingredients. The company focuses on multiple therapeutic areas including diabetic, cardiovascular, oncology, anesthetic and analgesic treatments, and operates manufacturing facilities that have passed relevant GMP standards to support quality and compliance in production of its pharmaceutical products.

norepinephrine bitartrate

Injection 4 mg/4 mL

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
FDA
Manufacturer #36628

Established in 1986, this manufacturer employs approximately 1,451 individuals and specializes in heparin-related products, including standard heparin and low molecular weight heparin. As a CTD dossier owner and manufacturer, it holds GMP approvals from multiple countries, ensuring compliance with international quality standards. The manufacturer operates advanced production lines for both active pharmaceutical ingredients and finished dosage forms, adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in over 60 countries worldwide

norepinephrine bitartrate

Solution for injection 2mg - 1ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Unavailable markets
Cambodia , Philippines
Registered in
Cambodia , Philippines
Available for
Licensing with supply, Distribution only
MAs available in
Cambodia , Philippines
Manufacturer #31099

This research-based international pharmaceutical enterprise specializes in pharmaceutical technology, nuclear medicine anti-tumor diagnosis and treatment, and cerebro-cardiovascular precision interventional diagnosis and treatment technology. They possess a diverse product pipeline spanning various medical therapeutic areas, including ENT, respiratory and critical care diseases, cerebro-cardiovascular conditions, and pharmaceutical raw materials. The company has established eight R&D centers globally, with key locations in North America, Europe, Australia, and Asia. They prioritize innovative product development, evidenced by their mRNA platform, DNA technology for tumor DNA immunotherapy, and glycomics technology platform for antiviral drug research. Their commitment to quality is reflected in their GMP certifications and patent-protected products.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.